5S-HETE

5s-hete is a lipid of Fatty Acyls (FA) class. 5s-hete often locates in Microsomes.

Cross Reference

Introduction

To understand associated biological information of 5S-HETE, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 5S-HETE?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 5S-HETE

MeSH term MeSH ID Detail
Mastocytosis D008415 5 associated lipids
Carotid Artery Injuries D020212 8 associated lipids
Obstetric Labor, Premature D007752 9 associated lipids
Leukemia, Basophilic, Acute D015471 9 associated lipids
Familial Mediterranean Fever D010505 12 associated lipids
Bronchial Spasm D001986 18 associated lipids
Pregnancy Complications D011248 19 associated lipids
Gastrointestinal Diseases D005767 20 associated lipids
Helicobacter Infections D016481 21 associated lipids
Vomiting D014839 21 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Coronary Disease D003327 70 associated lipids
Leukemia D007938 74 associated lipids
Arteriosclerosis D001161 86 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Per page 10 20 | Total 16

PubChem Associated disorders and diseases

What pathways are associated with 5S-HETE

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 5S-HETE?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 5S-HETE?

There are no associated biomedical information in the current reference collection.

What lipids are associated with 5S-HETE?

There are no associated biomedical information in the current reference collection.

What genes are associated with 5S-HETE?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 5S-HETE?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 5S-HETE

Download all related citations
Per page 10 20 50 100 | Total 789
Authors Title Published Journal PubMed Link
Sperling RI et al. Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. 1993 J. Clin. Invest. pmid:8381824
Capodici C et al. Integrin-dependent homotypic adhesion of neutrophils. Arachidonic acid activates Raf-1/Mek/Erk via a 5-lipoxygenase- dependent pathway. 1998 J. Clin. Invest. pmid:9649570
Laviolette M et al. Decreased leukotriene B4 synthesis in smokers' alveolar macrophages in vitro. 1986 J. Clin. Invest. pmid:3003154
Klickstein LB et al. Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis. 1980 J. Clin. Invest. pmid:6253525
Brown ML et al. Elevated glucose alters eicosanoid release from porcine aortic endothelial cells. 1988 J. Clin. Invest. pmid:3143746
Miyake A et al. Possible involvement of lipoxygenase pathway of arachidonic acid in rat pituitary hormone release in vitro. 1988 J. Endocrinol. Invest. pmid:2852195
Romanelli F et al. Arachidonic acid and its metabolites effects on testosterone production by rat Leydig cells. 1995 J. Endocrinol. Invest. pmid:7615904
Goldman DW and Goetzl EJ Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B4. Identification of a subset of high affinity receptors that transduce the chemotactic response. 1984 J. Exp. Med. pmid:6323613
Dahinden CA et al. Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals. 1988 J. Exp. Med. pmid:2833556
Goetzl EJ and Pickett WC Novel structural determinants of the human neutrophil chemotactic activity of leukotriene B. 1981 J. Exp. Med. pmid:6264017
Grimminger F et al. Inflammatory lipid mediator generation elicited by viable hemolysin-forming Escherichia coli in lung vasculature. 1990 J. Exp. Med. pmid:2120384
Pawlowski NA et al. Uptake and metabolism of monohydroxy-eicosatetraenoic acids by macrophages. 1982 J. Exp. Med. pmid:6951919
Green FA et al. Monohydroxyeicosatetraenoic acid and leukotriene production by the inflammatory cells of Xenopus laevis. 1987 J. Exp. Zool. pmid:2821155
Grimminger F et al. Influence of microvascular adherence on neutrophil leukotriene generation. Evidence for cooperative eicosanoid synthesis. 1990 J. Immunol. pmid:2155266
Peters SP et al. Arachidonic acid metabolism in purified human lung mast cells. 1984 J. Immunol. pmid:6199420
Johnson HM et al. Second messenger role of arachidonic acid and its metabolites in interferon-gamma production. 1986 J. Immunol. pmid:2877026
Powell WS et al. 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration. 1995 J. Immunol. pmid:7706749
O'Flaherty JT et al. Metabolism of 5-hydroxyicosatetraenoate by human neutrophils: production of a novel omega-oxidized derivative. 1986 J. Immunol. pmid:3095426
Dahinden CA et al. Stereospecificity of leukotriene B4 and structure-function relationships for chemotaxis of human neutrophils. 1984 J. Immunol. pmid:6086758
Sozzani S et al. Stimulating properties of 5-oxo-eicosanoids for human monocytes: synergism with monocyte chemotactic protein-1 and -3. 1996 J. Immunol. pmid:8906847
Rand TH et al. Arachidonic acid metabolism of the murine eosinophil. II. Involvement of the lipoxygenase pathway in the response to the lymphokine eosinophil stimulation promoter. 1982 J. Immunol. pmid:6286759
Robinson BS et al. Inhibition of neutrophil leukotriene B4 production by a novel synthetic N-3 polyunsaturated fatty acid analogue, beta-oxa 21:3n-3. 2003 J. Immunol. pmid:14568954
Farrar WL and Humes JL The role of arachidonic acid metabolism in the activities of interleukin 1 and 2. 1985 J. Immunol. pmid:3924998
Bigby TD and Meslier N Transcellular lipoxygenase metabolism between monocytes and platelets. 1989 J. Immunol. pmid:2550547
O'Flaherty JT et al. Mechanism involved in the mobilization of neutrophil calcium by 5-hydroxyeicosatetraenoate. 1988 J. Immunol. pmid:2836511
Schulam PG and Shearer WT Evidence for 5-lipoxygenase activity in human B cell lines. A possible role for arachidonic acid metabolites during B cell signal transduction. 1990 J. Immunol. pmid:2108210
Williams JD et al. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan. 1985 J. Immunol. pmid:2982947
Razin E et al. An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells. 1984 J. Immunol. pmid:6330206
Tommasini I et al. Prostaglandin E2 signals monocyte/macrophage survival to peroxynitrite via protein kinase A converging in bad phosphorylation with the protein kinase C alpha-dependent pathway driven by 5-hydroxyeicosatetraenoic acid. 2008 J. Immunol. pmid:18832722
O'Flaherty JT and Nishihira J Arachidonate metabolites, platelet-activating factor, and the mobilization of protein kinase C in human polymorphonuclear neutrophils. 1987 J. Immunol. pmid:3029224
Schulam PG et al. Platelet-activating factor induces phospholipid turnover, calcium flux, arachidonic acid liberation, eicosanoid generation, and oncogene expression in a human B cell line. 1991 J. Immunol. pmid:1847170
Heidel JR et al. Functional studies of bovine alveolar neutrophils elicited with recombinant bovine IL-1 beta. 1990 J. Immunol. pmid:2153175
Bass DA et al. Stimulation of hexose uptake by human eosinophils with chemotactic factors. 1981 J. Infect. Dis. pmid:7240808
Schröder JM Anthralin (1,8-dihydroxyanthrone) is a potent inhibitor of leukotriene production and LTB4-omega oxidation by human neutrophils. 1986 J. Invest. Dermatol. pmid:3021863
Soter NA The skin in mastocytosis. 1991 J. Invest. Dermatol. pmid:1672136
Grabbe J et al. Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin. 1984 J. Invest. Dermatol. pmid:6096449
Zhang Y et al. Synthesis of 5-oxo-6,8,11,14-eicosatetraenoic acid by human monocytes and lymphocytes. 1996 J. Leukoc. Biol. pmid:8691070
Rodriguez de Turco EB and Spitzer JA Eicosanoid production in nonparenchymal liver cells isolated from rats infused with E. coli endotoxin. 1990 J. Leukoc. Biol. pmid:2172432
Goya T et al. Characteristics of alveolar macrophages in experimental septic lung. 1992 J. Leukoc. Biol. pmid:1324290
Taylor SM et al. Arachidonic and eicosapentaenoic acid metabolism in bovine neutrophils and platelets: effect of calcium ionophore. 1987 J. Leukoc. Biol. pmid:3040877
Werz O et al. p38 MAP kinase mediates stress-induced leukotriene synthesis in a human B-lymphocyte cell line. 2001 J. Leukoc. Biol. pmid:11698504
Webb DS and Roth JA Relationship of glucocorticoid suppression of arachidonic acid metabolism to alteration of neutrophil function. 1987 J. Leukoc. Biol. pmid:3027218
Tommasini I et al. 5-Hydroxyeicosatetraenoic acid is a key intermediate of the arachidonate-dependent protective signaling in monocytes/macrophages exposed to peroxynitrite. 2006 J. Leukoc. Biol. pmid:16885503
Heidel JR et al. Characterization of arachidonic acid metabolism, superoxide production, and bacterial killing in bovine circulating neutrophils and elicited alveolar neutrophils. 1989 J. Leukoc. Biol. pmid:2543724
Draganov DI et al. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. 2005 J. Lipid Res. pmid:15772423
Dadaian M and Westlund P Albumin modifies the metabolism of hydroxyeicosatetraenoic acids via 12-lipoxygenase in human platelets. 1999 J. Lipid Res. pmid:10224163
Zimmer JS et al. Fatty acid binding proteins stabilize leukotriene A4: competition with arachidonic acid but not other lipoxygenase products. 2004 J. Lipid Res. pmid:15342681
Bhatia PA et al. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones. 1996 J. Med. Chem. pmid:8831760
Hamer RR et al. Dibenzoxepinone hydroxylamines and hydroxamic acids: dual inhibitors of cyclooxygenase and 5-lipoxygenase with potent topical antiinflammatory activity. 1996 J. Med. Chem. pmid:8568814
Watanabe T et al. Participation of lipoxygenase products from arachidonic acid in the pathogenesis of cerebral vasospasm. 1988 J. Neurochem. pmid:3126264
Shimizu T et al. Activation of the arachidonate 5-lipoxygenase pathway in the canine basilar artery after experimental subarachnoidal hemorrhage. 1988 J. Neurochem. pmid:2843605
Adesuyi SA et al. Lipoxygenase metabolism of arachidonic acid in brain. 1985 J. Neurochem. pmid:3928809
Piomelli D et al. Metabolites of arachidonic acid in the nervous system of Aplysia: possible mediators of synaptic modulation. 1987 J. Neurosci. pmid:3119791
Cleland LG et al. Dietary (n-9) eicosatrienoic acid from a cultured fungus inhibits leukotriene B4 synthesis in rats and the effect is modified by dietary linoleic acid. 1996 J. Nutr. pmid:8648425
Hwang DH et al. Dietary linolenic acid and longer-chain n-3 fatty acids: comparison of effects on arachidonic acid metabolism in rats. 1988 J. Nutr. pmid:2895804
Dannhardt G and Lehr M In-vitro evaluation of 5-lipoxygenase and cyclo-oxygenase inhibitors using bovine neutrophils and platelets and HPLC. 1992 J. Pharm. Pharmacol. pmid:1359057
Tavares IA et al. Effects of isoxicam and other non-steroidal anti-inflammatory drugs on arachidonic acid metabolism by rat peritoneal leucocytes. 1985 J. Pharm. Pharmacol. pmid:2864427
Jacobson PB and Jacobs RS Fuscoside: an anti-inflammatory marine natural product which selectively inhibits 5-lipoxygenase. Part II: Biochemical studies in the human neutrophil. 1992 J. Pharmacol. Exp. Ther. pmid:1323665
MacNaughton WK et al. A role for phospholipid-derived inflammatory mediators in intestinal anaphylaxis in the rat. 1992 J. Pharmacol. Exp. Ther. pmid:1738123
Hevko JM et al. Synthesis of 5-oxo-6,8,11,14-eicosatetraenoic acid and identification of novel omega-oxidized metabolites in the mouse macrophage. 2001 J. Pharmacol. Exp. Ther. pmid:11160610
Burstein SH et al. Antagonism to the actions of platelet activating factor by a nonpsychoactive cannabinoid. 1989 J. Pharmacol. Exp. Ther. pmid:2553925
Smith SR et al. Actions of a 5-lipoxygenase inhibitor, Sch 40120, on acute inflammatory responses. 1992 J. Pharmacol. Exp. Ther. pmid:1386887
Wegmann M et al. Effect of hydroxyeicosatetraenoic acids on furosemide-sensitive chloride secretion in rat distal colon. 2000 J. Pharmacol. Exp. Ther. pmid:10991970
Fiedler J et al. Exogenous leukotriene B4 (LTB4) inhibits human neutrophil generation of LTB4 from endogenous arachidonic acid during opsonized zymosan phagocytosis. 1998 J. Pharmacol. Exp. Ther. pmid:9765334
Erman A et al. Treatment with dexamethasone increases glomerular prostaglandin synthesis in rats. 1986 J. Pharmacol. Exp. Ther. pmid:3093672
Patel P et al. Substrate selectivity of 5-hydroxyeicosanoid dehydrogenase and its inhibition by 5-hydroxy-Delta6-long-chain fatty acids. 2009 J. Pharmacol. Exp. Ther. pmid:19164464
Ritchie DM et al. Evaluation of calcium entry blockers in several models of immediate hypersensitivity. 1984 J. Pharmacol. Exp. Ther. pmid:6202868
Gillespie MN et al. Salutary effects of prostaglandin E1 in perfused rat lungs injured with hydrogen peroxide. 1987 J. Pharmacol. Exp. Ther. pmid:3033198
Warner JA et al. Effects of a specific inhibitor of the 5-lipoxygenase pathway on mediator release from human basophils and mast cells. 1988 J. Pharmacol. Exp. Ther. pmid:3139865
Patel P et al. Structural requirements for activation of the 5-oxo-6E,8Z, 11Z,14Z-eicosatetraenoic acid (5-oxo-ETE) receptor: identification of a mead acid metabolite with potent agonist activity. 2008 J. Pharmacol. Exp. Ther. pmid:18292294
Edwin SS et al. Action of immunoregulatory agents on 5-HETE production by cultured human amnion cells. 1997 J. Reprod. Immunol. pmid:9430742
Wang XJ et al. Involvement of 5-lipoxygenase metabolites of arachidonic acid in cyclic AMP-stimulated steroidogenesis and steroidogenic acute regulatory protein gene expression. 2003 J. Steroid Biochem. Mol. Biol. pmid:12943700
Shimanuki T et al. A kinetic analysis of peritoneal fluid cytology and arachidonic acid metabolism after abrasion and reabrasion of rabbit peritoneum. 1986 J. Surg. Res. pmid:3463833
Gillis RC et al. Regulation of apoptosis in eicosapentaenoic acid-treated HL-60 cells. 2007 J. Surg. Res. pmid:17084410
Sanna F et al. Production of inflammatory molecules in peripheral blood mononuclear cells from severely glucose-6-phosphate dehydrogenase-deficient subjects. 2007 J. Vasc. Res. pmid:17361089
Kuzuya T et al. Altered lipoxygenase metabolites and leukocyte involvement in an acute occlusion-reperfusion model of canine myocardial infarction. 1987 Jpn. Circ. J. pmid:3112436
Shibata N et al. Augmentation of eicosanoids in ischemic heart muscle in dogs: its role in the deterioration of the ischemic lesion. 1988 Jpn. Circ. J. pmid:3141656
Dohi T et al. Inhibition of lipoxygenase by phenolic compounds. 1991 Jpn. J. Pharmacol. pmid:1909391
Ono N et al. Pharmacological studies on proglumetacin maleate, a new non-steroidal anti-inflammatory drug (4). Mode of action on anti-inflammatory activity. 1986 Jpn. J. Pharmacol. pmid:3102823
Parker CW Pharmacologic mediators of bronchoconstriction. 1980 Jpn. J. Pharmacol. pmid:6113295
Grabbe J et al. Chemotactic leukotrienes in psoriasis. 1982 Lancet pmid:6129537
Rossi AG and O'Flaherty JT Bioactions of 5-hydroxyicosatetraenoate and its interaction with platelet-activating factor. 1991 Lipids pmid:1668115
Beckman JK et al. Stimulation by lipoxygenase products of superoxide anion production in FMLP-treated neutrophils. 1985 Lipids pmid:2989652
Nakamura T et al. Appearance of 5-hydroxy eicosatetraenoic acid in cerebrospinal fluid after subarachnoid haemorrhage. 1984 Med. Biol. pmid:6471929
McCarty M Can dietary selenium reduce leukotriene production? 1984 Med. Hypotheses pmid:6323934
Di Girolamo G et al. [Effect of nonsteroidal antiinflammatory drugs on colonic lipoxygenase and cyclooxygenase activities from patients with colonic neoplasia]. 2001 Medicina (B Aires) pmid:11721323
Franchi A et al. [Differential action of non-steroidal antiinflammatory drugs on human gallbladder cyclooxygenase and lipoxygenase]. 2000 Medicina (B Aires) pmid:11188896
Jakschik BA et al. The 5-lipoxygenase and leukotriene forming enzymes. 1982 Meth. Enzymol. pmid:6813642
Ogletree ML et al. Measurement of 5-hydroxyeicosatetraenoic acid (5-HETE) in biological fluids by GC-MS. 1982 Meth. Enzymol. pmid:7132773
He C et al. Dynamic eicosanoid responses upon different inhibitor and combination treatments on the arachidonic acid metabolic network. 2012 Mol Biosyst pmid:22446875
Chatterjee M et al. Overexpression of 5-lipoxygenase and its relation with cell proliferation and angiogenesis in 7,12-dimethylbenz(α)anthracene-induced rat mammary carcinogenesis. 2013 Mol. Carcinog. pmid:22213124
Coty WA and Pedersen PL Phosphate transport in rat liver mitochondria. Kinetics, inhibitor sensitivity, energy requirements, and labeled components. 1975 Mol. Cell. Biochem. pmid:609
Yu CL et al. Serum stimulation of NIH 3T3 cells induces the production of lipids able to inhibit GTPase-activating protein activity. 1990 Mol. Cell. Biol. pmid:2174114
Velardez MO et al. Role of nitric oxide in the metabolism of arachidonic acid in the rat anterior pituitary gland. 2001 Mol. Cell. Endocrinol. pmid:11165034
Grimminger F et al. Inhibition of cytoskeletal rearrangement by botulinum C2 toxin amplifies ligand-evoked lipid mediator generation in human neutrophils. 1991 Mol. Pharmacol. pmid:1656192
Jones CE et al. Expression and characterization of a 5-oxo-6E,8Z,11Z,14Z-eicosatetraenoic acid receptor highly expressed on human eosinophils and neutrophils. 2003 Mol. Pharmacol. pmid:12606753
Grimminger F et al. Ligand-operated synthesis of 4-series and 5-series leukotrienes in human neutrophils: critical dependence on exogenous free fatty acid supply. 1992 Mol. Pharmacol. pmid:1569925
Peters SP et al. Lipoxygenase products modulate histamine release in human basophils. 1981 Nature pmid:6166867
Dolegowska B et al. Lipoxygenase-derived hydroxyeicosatetraenoic acids--novel perioperative markers of early post-transplant allograft function? 2010 Nephrol. Dial. Transplant. pmid:20530808
Vacas MI et al. Involvement of 5-lipoxygenase pathway in norepinephrine stimulation of rat pineal melatonin synthesis. 1987 Neuroendocrinology pmid:3431657